Kathryn DiMarco
Comptroller/Controller/Auditor en ORGANON & CO. .
Fortuna: 378 820 $ al 31/03/2024
Perfil
Kathryn DiMarco is currently the Senior Vice President-Finance & Controller at Organon & Co. Prior to this, she worked as the Controller at Allergan Ltd.
(Ireland) from 2015 to 2020 and as the International Controller at Merck Sharp & Dohme Corp.
from 2014 to 2015.
She obtained her undergraduate degree from Lehigh University.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
ORGANON & CO.
0.01% | 31/03/2024 | 20 150 ( 0.01% ) | 378 820 $ | 31/03/2024 |
Cargos activos de Kathryn DiMarco
| Empresas | Cargo | Inicio |
|---|---|---|
| ORGANON & CO. | Comptroller/Controller/Auditor | 02/06/2021 |
Antiguos cargos conocidos de Kathryn DiMarco.
| Empresas | Cargo | Fin |
|---|---|---|
| ALLERGAN PLC | Comptroller/Controller/Auditor | 01/01/2020 |
Merck Sharp & Dohme Corp.
 Merck Sharp & Dohme Corp. Pharmaceuticals: MajorHealth Technology Merck Sharp & Dohme Corp. engages in the research, development, and distribution of vaccines, prescription drugs, and animal health products. The company is headquartered in Whitehouse Station, NJ. | Comptroller/Controller/Auditor | 01/01/2015 |
Formación de Kathryn DiMarco.
| Lehigh University | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| ORGANON & CO. | Health Technology |
| Empresas privadas | 2 |
|---|---|
Merck Sharp & Dohme Corp.
Merck Sharp & Dohme Corp. Pharmaceuticals: MajorHealth Technology Merck Sharp & Dohme Corp. engages in the research, development, and distribution of vaccines, prescription drugs, and animal health products. The company is headquartered in Whitehouse Station, NJ. | Health Technology |
Allergan Ltd. (Ireland)
 Allergan Ltd. (Ireland) Pharmaceuticals: MajorHealth Technology Allergan Plc engages in the research, development, and manufacture of pharmaceutical products. It operates through the following business segments: US Specialized Therapeutics; US General Medicine, and International. The US Specialized Therapeutics segment includes sales and expenses relating to branded products within the United States. The US General Medicine segment involves Central Nervous System; Gastrointestinal; Women's Health; Anti-Infectives; and Diversified brands. The International segment comprises of products sold outside the United States. The company was founded in 1982 and is headquartered in Dublin, Ireland. | Health Technology |
- Bolsa de valores
- Insiders
- Kathryn DiMarco
